Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2406332121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Evan R Abt und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90095. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Epitopes, T-Lymphocyte, SARS-CoV-2, mRNA Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, California HIV/AIDS Research Program (CHRP), NIGMS NIH HHS.
Abstract (Originalsprache)
Combining a T cell-targeting mRNA vaccine encoding the conserved SARS-CoV-2 RNA-dependent RNA polymerase, RdRp, with a Spike-encoding mRNA vaccine may offer an additional pathway toward COVID-19 protection. Here, we show that a nucleoside-modified RdRp mRNA vaccine raises robust and durable CD8+ T cell responses in mice. Immunization drives a CD8+ T cell response enriched toward a specific RdRp epitope. Unexpectedly, coadministration of mRNA vaccines encoding RdRp or the Spike Receptor Binding Domain (RBD) dampens RBD-specific immune responses. Contralateral administration reduces the suppression of RBD-specific T cell responses while type I interferon signaling blockade restores RBD-specific antibodies. A staggered immunization strategy maintains both RBD vaccine-mediated antibody and T cell responses as well as protection against lethal SARS-CoV-2 challenge in human ACE2 transgenic mice. In HLA-A2.1 transgenic mice, the RdRp vaccine elicits CD8+ T cell responses against HLA-A*02:01-restricted epitopes recognized by human donor T cells. These results highlight RdRp as a candidate antigen for COVID-19 vaccines. The findings also offer insights into crafting effective multivalent mRNA vaccines to broaden CD8+ T cell responses against SARS-CoV-2 and potentially other viruses with pandemic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90095.
- Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095.
- Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
- Department of Molecular Microbiology and Immunology, The Hastings and Wright Laboratories, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90095.
ORCID-Profile: Evan R Abt, Alex K Lam, Ying K Tam, Norbert Pardi, Vaithilingaraja Arumugaswami, Owen N Witte, Caius G Radu
Förderung
- NCI NIH HHS
- California HIV/AIDS Research Program (CHRP)
- NIGMS NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
Zitieren
APA
Abt, E. R., Lam, A. K., Noguchi, M., Rashid, K., McLaughlin, J., Teng, P. L., Tran, W., Cheng, D., Nesterenko, P. A., Mao, Z., Creech, A. L., Burton Sojo, G., Jeyachandran, A. V., Tam, Y. K., Henley, J. E., Comai, L., Pardi, N., Arumugaswami, V., Witte, O. N., …, & Wu, T. T. (2024). Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2406332121
Vancouver
Abt ER, Lam AK, Noguchi M, Rashid K, McLaughlin J, Teng PL, et al. Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2406332121
BibTeX
@article{Abt2024,
author = {Abt, Evan R and Lam, Alex K and Noguchi, Miyako and Rashid, Khalid and McLaughlin, Jami and Teng, Pu-Lin and Tran, Wendy and Cheng, Donghui and Nesterenko, Pavlo A and Mao, Zhiyuan and Creech, Amanda L and Burton Sojo, Giselle and Jeyachandran, Arjit Vijey and Tam, Ying K and Henley, Jill E and Comai, Lucio and Pardi, Norbert and Arumugaswami, Vaithilingaraja and Witte, Owen N and Radu, Caius G and Wu, Ting-Ting},
title = {Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2406332121}
}
EUVIMED